Allodynia in migraine: frequent random association or unavoidable consequence?

References

• Moskowitz MA, Macfarlane R. Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc. Brain Metab. Rev.5, 159–177 (1993).
   PubMedGoogle Scholar
• Silberstein SD. Migraine pathophysiology and its clinical implications. Cephalalgia24(Suppl. 2), 2–7 (2004).
   PubMed Web of Science ®Google Scholar
• Nissan GR, Diamond ML. Advances in migraine treatment. J. Am. Osteopath. Assoc.105(4 Suppl. 2), S9 (2005).
   Google Scholar
• Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat. Med.8, 136–142 (2002).
   PubMed Web of Science ®Google Scholar
• Burstein R, Jakubowski M. Unitary hypothesis for multiple triggers of the pain and strain of migraine. J. Comp. Neurol.493, 9–14 (2005).
   PubMed Web of Science ®Google Scholar
• Knight Y. Brainstem modulation of caudal trigeminal nucleus: a model for understanding migraine biology and future drug targets. Headache Currents2, 108–118 (2005).
   Google Scholar
• Oshinsky ML, Luo J. Neurochemistry of trigeminal activation in an animal model of migraine. Headache46(Suppl. 1), S39–S44 (2006).
   PubMed Web of Science ®Google Scholar
• Piovesan EJ, Di Stani F, Kowacs PA et al. Massaging over the greater occipital nerve reduces the intensity of migraine attacks: evidence for inhibitory trigemino-cervical convergence mechanisms. Arq. Neuropsiquiatr.65(3A), 599–604 (2007).
   PubMed Web of Science ®Google Scholar
• Bartsch T. Migraine and the neck: new insights from basic data. Curr. Pain Headache Rep.9(3), 191–196 (2005).
   PubMedGoogle Scholar
• Schürks M, Diener HC. Pathophysiology of migraine and clinical implications. Schmerz22(5), 523–530 (2008).
   PubMed Web of Science ®Google Scholar
• Young W, Cook B, Malik S, Shaw J, Oshinsky M. The first 5 minutes after greater occipital nerve block. Headache48(7), 1126–1128 (2008).
   PubMed Web of Science ®Google Scholar
• Busch V, Frese A, Bartsch T. The trigemino–cervical complex. Integration of peripheral and central pain mechanisms in primary headache syndromes. Schmerz18(5), 404–410 (2004).
   PubMed Web of Science ®Google Scholar
• Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann. Neurol.47(5), 614–624 (2000).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ. Migraine, allodynia, sensitisation and all of that… Eur. Neurol.53(Suppl. 1), 10–16 (2005).
   PubMed Web of Science ®Google Scholar
• Landy S, Rice K, Lobo B. Central sensitisation and cutaneous allodynia in migraine: implications for treatment. CNS Drugs18(6), 337–342 (2004).
   PubMed Web of Science ®Google Scholar
• Mathew NT, Kailasam J, Seifert T. Clinical recognition of allodynia in migraine. Neurology63(5), 848–852 (2004).
   PubMed Web of Science ®Google Scholar
• Lovati C, D’Amico D, Bertora P et al. Acute and interictal allodynia in patients with different headache forms: an Italian pilot study. Headache48(2), 272–277 (2008).
   PubMed Web of Science ®Google Scholar
• Young WB, Richardson ES, Shukla P. Brush allodynia in hospitalized headache patients. Headache45(8), 999–1003 (2005).
   PubMed Web of Science ®Google Scholar
• Kitaj MB, Klink M. Pain thresholds in daily transformed migraine versus episodic migraine headache patients. Headache45(8), 992–998 (2005)
   PubMed Web of Science ®Google Scholar
• Jakubowski M, Silberstein S, Ashkenazi A, Burstein R. Can allodynic migraine patients be identified interictally using a questionnaire? Neurology65, 1419–1422 (2005).
   PubMed Web of Science ®Google Scholar
• Bouhassira D, Attal N, Willer JC, Brasseur L. Painful and painless peripheral sensory neuropathies due to HIV infection: a comparison using quantitative sensory evaluation. Pain80, 265–272 (1999).
   PubMed Web of Science ®Google Scholar
• Martinez V, Fletcher D, Bouhassira D, Sessler DI, Chauvin M. The evolution of primary hyperalgesia in orthopedic surgery: quantitative sensory testing and clinical evaluation before and after total knee arthroplasty. Anesth. Analg.105(3), 815–821 (2007).
   PubMed Web of Science ®Google Scholar
• Treede RD, Kunde V. Middle-latency somatosensory evoked potentials after stimulation of the radial and median nerves: component structure and scalp topography. J. Clin. Neurophysiol.12(3), 291–301 (1995).
   PubMed Web of Science ®Google Scholar
• Lipton RB, Bigal ME, Ashina S et al. American Migraine Prevalence Prevention Advisory Group. Cutaneous allodynia in the migraine population. Ann. Neurol.63(2), 148–158 (2008).
   PubMed Web of Science ®Google Scholar
• Bahra A, Matharu MS, Buchel C et al. Brainstem activation specific to migraine headache. Lancet357, 1016–1017 (2001).
   PubMed Web of Science ®Google Scholar
• Ashina S, Bendtsen L, Ashina M et al. Generalized hyperalgesia in patients with chronic tension-type headache. Cephalalgia26, 940–948 (2006).
   PubMed Web of Science ®Google Scholar
• Landy SH, McGinnis JE, McDonald SA. Clarification of developing and established clinical allodynia and pain-free outcomes. Headache47(2), 247–252 (2007).
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Silberstein S, Jakubowski M, Burstein R. Improved identification of allodynic migraine patients using a questionnaire. Cephalalgia27(4), 325–329 (2007).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Ashina S, Burstein R et al.; AMPP Group. Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology70(17), 1525–1533 (2008).
   PubMed Web of Science ®Google Scholar
• Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain123(8), 1703–1709 (2000).
   PubMed Web of Science ®Google Scholar
• Weissman-Fogel I, Sprecher E, Granovsky Y, Yarnitsky D. Repeated noxious stimulation of the skin enhances cutaneous pain perception of migraine patients in-between attacks: clinical evidence for continuous sub-threshold increase in membrane excitability of central trigeminovascular neurons. Pain104(3), 693–700 (2003).
   PubMed Web of Science ®Google Scholar
• Zohsel K, Hohmeister J, Oelkers-Ax R, Flor H, Hermann C. Quantitative sensory testing in children with migraine: preliminary evidence for enhanced sensitivity to painful stimuli especially in girls. Pain123(1–2), 10–18 (2006).
   PubMed Web of Science ®Google Scholar
• Dodick D, Silberstein S. Central sensitization theory of migraine: clinical implications. Headache46(Suppl. 4), S182–S191 (2006).
   Google Scholar
• Biondi DM. Is migraine a neuropathic pain syndrome? Curr. Pain Headache Rep.10(3), 167–178 (2006).
   PubMedGoogle Scholar
• Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann. Neurol.55(1), 19–26 (2004).
   PubMed Web of Science ®Google Scholar
• Burstein R, Yamamura H, Malick A, Strassman AM. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J. Neurophysiol.79, 964–982 (1998).
   PubMed Web of Science ®Google Scholar
• Mitsikostas DD, Sanchez del Rio M. Receptor systems mediating c-fos expression within trigeminal nucleus caudalis in animal models of migraine. Brain Res. Rev.35, 20–35 (2001).
   PubMed Web of Science ®Google Scholar
• Cumberbatch MJ, Williamson DJ, Mason GS, Hill RG, Hargreaves RJ. Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist. Br. J. Pharmacol.126(6), 1478–1486 (1999).
   PubMed Web of Science ®Google Scholar
• Levy D, Jakubowski M, Burstein R. Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists. Proc. Natl Acad. Sci. USA101(12), 4274–4279 (2004).
   PubMed Web of Science ®Google Scholar
• Burstein R, Jakubowski M. Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann. Neurol.55(1), 27–36 (2004).
   PubMed Web of Science ®Google Scholar
• Vikelis M, Mitsikostas DD. The role of glutamate and its receptors in migraine. CNS Neurol. Disord. Drug Targets6(4), 251–257 (2007).
   PubMedGoogle Scholar
• Rogawski MA. Common pathophysiologic mechanisms in migraine and epilepsy. Arch. Neurol.65(6), 709–714 (2008).
   PubMedGoogle Scholar
• Sang CN, Ramadan NM, Wallihan et al. LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine. Cephalalgia24, 596–602 (2004).
   PubMed Web of Science ®Google Scholar
• Ramadan NM. The link between glutamate and migraine. CNS Spectr.8, 446–449 (2003).
   PubMed Web of Science ®Google Scholar
• Ren K, Dubner R. Pain facilitation and activity-dependent plasticity in pain modulatory circuitry: role of BDNF-TrkB signaling and NMDA receptors. Mol. Neurobiol.35(3), 224–235 (2007).
   PubMed Web of Science ®Google Scholar
• Petrenko AB, Yamakura T, Baba H, Shimoji K. The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review. Anesth. Analg.97(4), 1108–1116 (2003).
   PubMed Web of Science ®Google Scholar
• Levy D, Burstein R, Strassman AM. Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine. Ann. Neurol.58(5), 698–705 (2005).
   PubMed Web of Science ®Google Scholar
• Giniatullin R, Nistri A, Fabbretti E. Molecular mechanisms of sensitization of pain-transducing P2X3 receptors by the migraine mediators CGRP and NGF. Mol. Neurobiol.37(1), 83–90 (2008).
   PubMed Web of Science ®Google Scholar
• Benemei S, Nicoletti P, Capone JA, Geppetti P. Pain pharmacology in migraine: focus on CGRP and CGRP receptors. Neurol. Sci.28(Suppl. 2), S89–S93 (2007).
   Google Scholar
• Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache41, 638–645 (2001).
   PubMed Web of Science ®Google Scholar
• Lipton RB, Pan J. Is migraine a progressive brain disease? JAMA291, 493–494 (2004).
   PubMed Web of Science ®Google Scholar
• Srikiatkhachorn A. Pathophysiology of chronic daily headache. Curr. Pain Headache Rep.5(6), 537–544 (2001).
   PubMedGoogle Scholar
• Srikiatkhachorn A. Towards the better understanding about pathogenesis of chronic daily headache. J. Med. Assoc. Thai.89(Suppl. 3), S234–S243 (2006).
   Google Scholar
• Bigal ME, Lipton RB. Clinical course in migraine: conceptualizing migraine transformation. Neurology71(11), 848–855 (2008).
   PubMed Web of Science ®Google Scholar
• Lovati C, D’Amico D, Rosa S et al. Allodynia in different forms of migraine. Neurol. Sci.28(Suppl. 2), S220–S221 (2007).
   PubMed Web of Science ®Google Scholar
• Cooke L, Eliasziw M, Becker WJ. Cutaneous allodynia in transformed migraine patients. Headache47(4), 531–539 (2007).
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Sholtzow M, Shaw JW, Burstein R, Young WB. Identifying cutaneous allodynia in chronic migraine using a practical clinical method. Cephalalgia27(2), 111–117 (2007).
   PubMed Web of Science ®Google Scholar
• De Marinis M, Pujia A, Colaizzo E, Accornero N. The blink reflex in “chronic migraine”. Clin. Neurophysiol.118(2), 457–463 (2007).
   PubMed Web of Science ®Google Scholar
• Sand T, Zhitniy N, Nilsen KB, Helde G, Hagen K, Stovner LJ. Thermal pain thresholds are decreased in the migraine preattack phase. Eur. J. Neurol.15(11), 1199–1205 (2008).
   PubMed Web of Science ®Google Scholar
• Perrotta A, Bartolo M, Fiermonte G et al. Enhanced trigemino–cervical–spinal reflex recovery cycle in pain-free migraineurs. Headache45(8), 1061–1068 (2005).
   PubMed Web of Science ®Google Scholar
• Cuadrado ML, Young WB, Fernández-de-las-Peñas C, Arias JA, Pareja JA. Migrainous corpalgia: body pain and allodynia associated with migraine attacks. Cephalalgia28(1), 87–91 (2008).
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders (2nd edition).Cephalalgia24(Suppl. 1), 1–160 (2004).
   Web of Science ®Google Scholar
• Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann. Neurol.9(4), 344–352 (1981).
   PubMed Web of Science ®Google Scholar
• Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain117(1), 199–210 (1994).
   PubMed Web of Science ®Google Scholar
• LoPinto C, Young WB, Ashkenazi A. Comparison of dynamic (brush) and static (pressure) mechanical allodynia in migraine. Cephalalgia26(7), 852–856 (2006).
   PubMed Web of Science ®Google Scholar
• Huber G, Lampl C. Oxygen therapy influences episodic cluster headache and related cutaneous brush and cold allodynia. Headache49(1), 134–136 (2009).
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Young WB. Dynamic mechanical (brush) allodynia in cluster headache. Headache44(10), 1010–1012 (2004).
   PubMed Web of Science ®Google Scholar
• Ladda J, Straube A, Förderreuther S, Krause P, Eggert T. Quantitative sensory testing in cluster headache: increased sensory thresholds. Cephalalgia26(9), 1043–1050 (2006).
   PubMed Web of Science ®Google Scholar
• Filatova E, Latysheva N, Kurenkov A. Evidence of persistent central sensitization in chronic headaches: a multi-method study. J. Headache Pain9(5), 295–300 (2008).
   PubMed Web of Science ®Google Scholar
• Staud R, Spaeth M. Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia. CNS Spectr.13(3 Suppl. 5), 12–17 (2008).
   PubMed Web of Science ®Google Scholar
• Peres MF, Zukerman E, Senne Soares CA, Alonso EO, Santos BF, Faulhaber MH. Cerebrospinal fluid glutamate levels in chronic migraine. Cephalalgia24(9), 735–739 (2004).
   PubMed Web of Science ®Google Scholar
• Tietjen GE, Herial NA, Hardgrove J, Utley C, White L. Migraine co-morbidity constellations. Headache47(6), 857–865 (2007).
   PubMed Web of Science ®Google Scholar
• Bradley LA. Pathophysiologic mechanisms of fibromyalgia and its related disorders. J. Clin. Psychiatry69(Suppl. 2), 6–13 (2008).
   PubMed Web of Science ®Google Scholar
• Puca FM, Antonaci F, Genco S, Savarese MA, Piazzolla G, Prudenzano MP. Psychologic factors in chronic headache: assessment by means of the SCL-90-R inventory. Cephalalgia9(1), 33–51 (1989).
   PubMed Web of Science ®Google Scholar
• Puca FM, Prudenzano AM, Savarese M, Genco S, Specchio LM. Stress, mood disorders and memory in headache. Int. J. Clin. Pharmacol. Res.17(2–3), 111–114 (1997).
   PubMedGoogle Scholar
• O’Bryant SE, Marcus DA, Rains JC, Penzien DB. Neuropsychology of migraine: present status and future directions. Expert Rev. Neurother.5(3), 363–370 (2005).
   PubMedGoogle Scholar
• O’Bryant SE, Marcus DA, Rains JC, Penzien DB. The neuropsychology of recurrent headache. Headache46(9), 1364–1376 (2006).
   PubMed Web of Science ®Google Scholar
• Ravishankar N, Demakis GJ. The neuropsychology of migraine. Dis. Mon.53(3), 156–161 (2007).
   PubMedGoogle Scholar
• Marcus DA. Central nervous system abnormalities in migraine. Expert Opin. Pharmacother.4(10), 1709–1715 (2003).
   PubMed Web of Science ®Google Scholar
• Cahana A, Forster A. Mechanisms by which acute orofacial pain becomes chronic. Rev. Stomatol. Chir. Maxillofac.107(3), 156–160 (2006).
   PubMedGoogle Scholar
• Lovati C, D’Amico D, Brambilla A, Mariani C, Bussone G. Personality profile and allodynic migraine. Neurol. Sci.29(Suppl. 1), S152–S154 (2008).
   Google Scholar
• Gazerani P, Andersen OK, Arendt-Nielsen L. A human experimental capsaicin model for trigeminal sensitization. Gender-specific differences. Pain118(1–2), 155–163 (2005).
   PubMed Web of Science ®Google Scholar
• Craft RM. Modulation of pain by estrogens. Pain132(Suppl. 1), S3–S12 (2007).
   PubMed Web of Science ®Google Scholar
• Diamond ML, Cady RK, Mao L et al. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines. Headache48(2), 248–258 (2008).
   PubMed Web of Science ®Google Scholar
• Freitag FG, Finlayson G, Rapoport AM et al.; AIMS Investigators. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS). Headache47(4), 519–530 (2007).
   PubMed Web of Science ®Google Scholar
• Dahlöf C. Cutaneous allodynia and migraine: another view. Curr. Pain Headache Rep.10(3), 231–238 (2006).
   PubMedGoogle Scholar
• Lampl C, Huber G, Haas S, Rittberger E, Diener HC. Difference in triptan effect in patients with migraine and early allodynia. Cephalalgia28(10), 1031–1038 (2008).
   PubMed Web of Science ®Google Scholar
• Cady R, Martin V, Mauskop A et al. Symptoms of cutaneous sensitivity pre-treatment and post-treatment: results from the rizatriptan TAME studies. Cephalalgia27(9), 1055–1060 (2007).
   PubMed Web of Science ®Google Scholar
• Fanciullacci M, De Cesaris F. Preventing chronicity of migraine. J. Headache Pain6(4), 331–333 (2005).
   PubMedGoogle Scholar
• D’Amico D, Moschiano F, Bussone G. Early treatment of migraine attacks with triptans: a strategy to enhance outcomes and patient satisfaction? Expert Rev. Neurother.6(7), 1087–1097 (2006).
   PubMedGoogle Scholar
• Silberstein SD, Young WB, Hopkins MM, Gebeline-Myers C, Bradley KC. Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trial. Headache47(6), 878–885 (2007).
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Young WB. The effects of greater occipital nerve block and trigger point injection on brush allodynia and pain in migraine. Headache45(4), 350–354 (2005).
   PubMed Web of Science ®Google Scholar
• Mellick LB, McIlrath ST, Mellick GA. Treatment of headaches in the emergency department with lower cervical intramuscular bupivacaine injections: a 1-year retrospective review of 417 patients. Headache46(9), 1441–1449 (2006).
   PubMed Web of Science ®Google Scholar
• Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Bajwa Z, Burstein R. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache45(7), 850–861 (2005).
   PubMed Web of Science ®Google Scholar
• Jakubowski M, Levy D, Kainz V, Zhang XC, Kosaras B, Burstein R. Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion. Neuroscience148(2), 573–583 (2007).
   PubMed Web of Science ®Google Scholar
• Levy D, Zhang XC, Jakubowski M, Burstein R. Sensitization of meningeal nociceptors: inhibition by naproxen. Eur. J. Neurosci.27(4), 917–922 (2008).
   PubMed Web of Science ®Google Scholar
• Krymchantowski AV, Bigal ME. Polytherapy in the preventive and acute treatment of migraine: fundamentals for changing the approach. Expert Rev. Neurother.6(3), 283–289 (2006).
   PubMedGoogle Scholar
• Galeotti N, Ghelardini C, Grazioli I, Uslenghi C. Indomethacin, caffeine and prochlorperazine alone and combined revert hyperalgesia in in vivomodels of migraine. Pharmacol. Res.46(3), 245–250 (2002).
   PubMed Web of Science ®Google Scholar
• Sandrini G, Cerbo R, Del Bene E et al. Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomized, parallel group, multicentre study. Int. J. Clin. Pract.61(8), 1256–1269 (2007).
   PubMed Web of Science ®Google Scholar
• Ghelardini C, Galeotti N, Grazioli I, Uslenghi C. Indomethacin, alone and combined with prochlorperazine and caffeine, but not sumatriptan, abolishes peripheral and central sensitization in in vivo models of migraine. J. Pain5(8), 413–419 (2004).
   PubMed Web of Science ®Google Scholar
• Schoenen J, De Klippel N, Giurgea S et al. Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodynia. Cephalalgia28(10), 1095–1105 (2008).
   PubMed Web of Science ®Google Scholar
• Brandes JL, Kudrow D, Stark SR et al. Sumatriptan–naproxen for acute treatment of migraine: a randomized trial. JAMA297(13), 1443–1454 (2007).
   PubMed Web of Science ®Google Scholar